HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nader Fotouhi Selected Research

2- (4- (4- (2,3- dihydroxy- propoxy)phenyl)- 2,5- dioxo- imidazolidin- 1- yl)- N- (2- fluoro- 4- iodo- phenyl)- 3- phenylbutyramide

1/2010Preclinical in vivo evaluation of efficacy, pharmacokinetics, and pharmacodynamics of a novel MEK1/2 kinase inhibitor RO5068760 in multiple tumor models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nader Fotouhi Research Topics

Disease

6Tuberculosis (Tuberculoses)
01/2022 - 01/2019
6Neoplasms (Cancer)
09/2013 - 02/2004
3Infections
11/2021 - 01/2019
1Extensively Drug-Resistant Tuberculosis
11/2021
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2021
1Asthma (Bronchial Asthma)
06/2010
1Inflammation (Inflammations)
06/2010
1Pneumonia (Pneumonitis)
06/2010
1Pulmonary Eosinophilia (Eosinophilic Pneumonia)
06/2010
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2010
1Chronic Obstructive Pulmonary Disease (COPD)
06/2010
1Acute Lung Injury
06/2010

Drug/Important Bio-Agent (IBA)

5Pharmaceutical PreparationsIBA
01/2022 - 01/2005
3bedaquiline (R207910)IBA
11/2021 - 01/2019
3Linezolid (Zyvox)FDA Link
11/2021 - 01/2019
3pretomanidIBA
11/2021 - 01/2019
2DiarylquinolinesIBA
11/2021 - 01/2021
2PyrazinamideFDA LinkGeneric
01/2021 - 01/2019
2Moxifloxacin (Avelox)FDA Link
01/2021 - 01/2019
2Mitogen-Activated Protein KinasesIBA
01/2010 - 03/2009
1Drug CombinationsIBA
01/2022
1Antitubercular AgentsIBA
01/2022
1TBAJ-876IBA
11/2021
1Mechanistic Target of Rapamycin Complex 2IBA
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2021
1Peptides (Polypeptides)IBA
09/2013
1Proteins (Proteins, Gene)FDA Link
09/2013
1ATSP-7041IBA
09/2013
1Leukotriene B4IBA
06/2010
14- (3- (6- (3- benzo(1,3)dioxol- 5- yl- 5- thiophen- 3- ylphenoxy)hexyl)- 2- (2- carboxyethyl)phenoxy)butyric acidIBA
06/2010
1Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA
06/2010
12- (4- (4- (2,3- dihydroxy- propoxy)phenyl)- 2,5- dioxo- imidazolidin- 1- yl)- N- (2- fluoro- 4- iodo- phenyl)- 3- phenylbutyramideIBA
01/2010
1Phosphotransferases (Kinase)IBA
01/2010
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2009
1MAP Kinase Kinase 1IBA
03/2009
1(2S,3S)- 2- ((R)- 4- (4- (2- hydroxyethoxy)phenyl)- 2,5- dioxo- imidazolidin- 1- yl)- 3- phenyl- N- (4- propionylthiazol- 2- yl)butyramideIBA
03/2009
1AgarIBA
02/2008
1Small Interfering RNA (siRNA)IBA
02/2008
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
02/2008
1Antineoplastic Agents (Antineoplastics)IBA
02/2008

Therapy/Procedure

4Therapeutics
01/2021 - 02/2004
2Duration of Therapy
01/2022 - 01/2019